Advertisement

TheBodyPRO.com covers ICAAC 2015

News

Five Promising HIV Drugs in the Pipeline

September 20, 2015

 1/7 

Five Promising HIV Drugs in the Pipeline

There are currently 28 drugs for the treatment of HIV approved by the U.S. Food and Drug Administration (FDA). But there's always room for improvement and more choices. At ICAAC/ICC 2015, Roy Gulick, M.D., provided a look into the antiretroviral therapy pipeline. Many new drugs are in development, both in existing classes and in new classes, but here are the five that are farthest along in clinical development.

Get Started





This article was provided by TheBodyPRO.com. It is a part of the publication The 55th Interscience Conference on Antimicrobial Agents and Chemotherapy.
 


 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.